Allergy Therapeutics PLC Stock
€0.085
Your prediction
Allergy Therapeutics PLC Stock
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
Cons
Performance of Allergy Therapeutics PLC vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Allergy Therapeutics PLC | 8.330% | 16.552% | 17.361% | 59.434% | 23.358% | -61.591% | - |
Beximco Pharmaceuticals Ltd. GDR | -2.380% | -0.485% | -0.485% | -4.206% | -0.966% | -47.436% | 12.637% |
SELLAS Life Sciences Group Inc | 5.000% | 18.519% | 30.044% | 63.504% | 90.436% | -15.232% | -27.829% |
Eledon Pharmaceuticals Inc. | -3.450% | -3.448% | -12.500% | -1.754% | -45.098% | -1.754% | -65.432% |
News

3 High-Yielding Dividend Stocks to Buy for the Long Haul
The average stock on the S&P 500 yields just 1.3%. That's a modest return on your money, but that's only the average. There are many dividend stocks that pay you much more than that. While you don't

This Dividend Stock Is Up 4 Times More Than the S&P 500 in the Past Year. Here's Why I'm Loading Up On It.
The S&P 500 (SNPINDEX: ^GSPC), the stock market's most widely followed index, has delivered slightly better than average returns over the past 12 months, rising by around 12%. However, the market's

AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio?
Investor focus on AT&T (NYSE: T) is starting to sharpen, with the company’s stock price making a healthy upward move of nearly 50% over the past year as of